Talinolol
CAS: 57460-41-0
Ref. 3D-FT111874
1mg | Ausgelaufen | ||
2mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen |
Produktinformation
- 1-(4-(3-(tert-butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylurea
- 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane
- 1-[3-(3-Cyclohexylureido)phenoxy]-3-(tert-butylamino)-2-propanol
- 1-[4-(Cyclohexylureido)phenoxy]-3-(tert-butylamino)-2-propanol
- 1-{4-[3-(tert-Butylamino)-2-hydroxypropoxy]phenyl}-3-cyclohexylurea
- 57460-41-0
- Cordanum
- N-Cyclohexyl-N′-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]urea
- Racemic talinolol
- Urea, N-cyclohexyl-N′-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-
- Mehr Synonyme anzeigen
Talinolol is a p-glycoprotein (p-gp) inhibitor that has been shown to be effective against infectious diseases such as HIV, hepatitis C, and malaria. Talinolol is used in the treatment of high blood pressure. It binds to the protein gene polymerase chain reaction, which inhibits transcription and replication of DNA. This drug also inhibits receptor activity in the intestines, leading to reduced absorption of drugs from the intestinal tract. Talinolol has an effect on water vapor in the lungs, which may lead to increased airway resistance after inhalation.